Gosta Labs, a Helsinki-based healthtech company developing an AI operating system for complex medical specialties, announced the close of a €7.5 million oversubscribed seed round led by Voima Ventures, with participation from COR Group, the Aho family, Reaktor, and several angel investors. The raise follows a €1.7 million pre-seed round and brings total funding to nearly €10 million. The company scales an oncology-focused system designed to convert every patient interaction into structured data in real time, streamline documentation, and support consistent, guideline-aligned treatment decisions for clinicians. The platform is already deployed with providers in Finland, Switzerland, the Baltics, and Australia.
Growing complexity in cancer care, combined with administrative burdens and fragmented clinical data, drives demand for modern AI support. Real-world results presented at ESMO 2025 indicate that the Gosta AI Operating System produces institution-standard consultation notes instantly and classifies key clinical parameters automatically. Oncologists using the system completed follow-up documentation in under two minutes.
“This technology is already reshaping our clinical workflows. The ability to produce structured, accurate notes instantly and classify key clinical parameters automatically frees oncologists to spend their time where it matters most — with their patients. In practice, this has already cut documentation time by over two-thirds for each patient visit at our cancer center", said Dr. Razvan Popescu, Medical Director at Tumor Center Aargau.
Founded in 2023 by Lauri Sippola and Henri Viertolahti, the founding team brings experience from Kaiku Health, acquired by Elekta in 2020, supported by oncology, medtech, and AI experts including Chief Medical Officer Dr. Lionel Hadjadjeba and Chief Operating Officer Reetta Arokoski.
“Gosta Labs’ key team members combine proven startup execution, deep domain expertise and top notch AI capabilities. They’ve done it before and know what good looks like, which is an essential for any startup team,” said Jussi Sainiemi, Partner at Voima Ventures.“There’s a lot of hype around AI but Gosta delivers the value it promises and customers love the product.”
“We started Gosta Labs to bring AI to support extremely complex medical specialties like oncology, to give care teams back time and headspace for their patients by taking on the documentation work that drains their day,” said Lauri Sippola. “This funding helps us bring our trusted AI assistant to oncology teams around the world and deepen our medical device grade product and AI foundation, so every patient encounter can be safer, more personal, and less burdened by administration.”